autologous human tumor-derived HSPPC-96

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent LymphomaNCT00081809AGENPhase 2Completed2005-06Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.